
National Association of Testing Authorities, Australia
Scope of Accreditation
echiDNA Pathology Labs Pty Ltd
Site
echiDNA Pathology Labs Pty Ltd
Accreditation No.
20642
Site No.
24747
Date of Accreditation
04 Dec 2025
Contact
Availability
Services available to external clients
Supervision
Not Applicable
Scope of Accreditation
echiDNA Pathology Labs Pty Ltd
ISO 15189 (2012)
Human Pathology
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
| Service | Product | Determinant |
|---|---|---|
Suspended Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Whole genome sequencing studies for inherited (germline) DNA/RNA changes | Extracted DNA | Variants in the nuclear genome |
ISO 15189 (2022)
Human Pathology
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
| Service | Product | Determinant |
|---|---|---|
| Molecular genetics - DNA extraction | Blood | Viable DNA; Viable DNA for sequencing |
| Plasma | Viable DNA | |
| Molecular genetics - DNA fragment size analysis | Extracted DNA | DNA fragment size determination |
| Molecular genetics - DNA sequencing | Extracted DNA | Sequenced DNA |
| Inherited (germline) whole exome sequencing; Sequenced DNA utilising massively parallel sequencing technologies | ||
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood; Extracted DNA | Fragile X |
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted panels for inherited (germline) DNA/RNA changes | Blood; Extracted DNA | Autosomal recessive single gene disorders; X-linked single gene disorders |
| Molecular genetics - Non-invasive prenatal (genetic) screening | Extracted DNA; Maternal plasma | Aneuploidy for chromosomes X and Y; Jacobs syndrome (XYY); Klinefelter syndrome (XXY); Rare autosome aneuploidy and segmental genomic imbalances; Trisomy 13, trisomy 18, trisomy 21; Trisomy X; Turners syndrome (SCA:XO) |
| Molecular genetics/Cytogenetics - Bioinformatic analysis | DNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
20642
Site No.
24747
Print date
16 Dec 2025
END OF SCOPE